University of Maryland physicians use ultrasound in novel way

June 17, 2001

For most moms-to-be, there is an audible sigh of relief

Physicians at the University of Maryland Medical Center are using a new ultrasound technique to detect increased risk of genetic abnormalities like Down syndrome and heart disorders in unborn babies.

The beauty of the ultrasound test -- called nuchal translucency screening -- is that it is accurate, non-invasive and is performed at 10-14 weeks, much earlier in the course of pregnancy than amniocentesis.

"Its key attribute is that it doesn't involve an invasive amniocentesis. We get reliable information without risk to child or mother," says Christopher Harman, M.D., director of the University of Maryland Medical Center's Division of Maternal and Fetal Medicine and professor of obstetrics, gynecology and reproductive sciences at the University of Maryland School of Medicine.

The nuchal translucency screening test involves using ultrasound to measure a specific area of the baby's neck that can be an early indicator of both genetic disorders and heart abnormalities. By measuring blood fluid in this limited region, physicians are able to assess risk for genetic abnormalities such as Down syndrome, which are known to be accompanied by abnormal distribution of fluid.

Ultrasound is a standard imaging tool that uses high-frequency sound waves to bounce off the body and create a picture. It is a highly anticipated test for many parents-to-be, allowing doctors to see how the baby is developing. It sometimes reveals the sex of the child.

But the diagnosis of genetic disorders like Down syndrome historically has meant undergoing amniocentesis, an invasive test that requires the insertion of a long hollow needle into the uterus to draw fluid from the sac surrounding the fetus for further testing. The test may be uncomfortable for the mother and there is a small chance of infection or injury to the fetus. There also is a small chance of miscarriage. This test typically is not performed until the fifteenth week of pregnancy or later.

Now, OB/GYN patients at the University of Maryland Medical Center can include nuchal translucency screening, an ultrasound procedure that takes about 10 minutes, as the first round of testing that any mom-to-be undergoes throughout the course of her pregnancy.

"Basically we're offering it to all who are concerned about the possibility of a chromosomal abnormality. It's a relatively quick and easy test that provides important information relating to both mom and child," says Dr. Harman. "We're convinced this is an important advance in fetal medicine."

Though this screening test is more commonly used in other countries, the University of Maryland Medical Center was the first of a growing number of sites in the United States certified by the Fetal Medicine Foundation to use nuchal translucency screening to diagnose genetic and chromosomal abnormalities.

"The University of Maryland Medical Center was the first in the country to have four certified physicians providing the service. We have had excellent results in our first 1,000 patients," says Dr. Harman.

Dr. Harman thinks it's a tool whose time has come. "This has presented us with an opportunity for very early assessment of risk for Down syndrome and other chromosomal abnormalities. For patients who may have a child with a genetic disorder, this is a tool that helps them prepare more thoroughly and as far in advance as possible."

Though some parents will learn that their child may have a serious disorder like Down Syndrome, for the overwhelming majority, the news will be reassuring.

"Almost every mother-to-be, regardless of her age, health or risk factors, has a nagging, underlying fear that her child may have a serious disease or disorder. This quick and simple test can yield some very valuable information that eliminates many potential worries and helps put a mother at ease. More often than not, we hear an audible sigh of relief," says Dr. Harman.
-end-
Additional Contact:
Ellen Beth Levitt (eblevitt@umm.edu)
410-328-8919

University of Maryland Medical Center

Related Pregnancy Articles from Brightsurf:

COVID-19 has a prolonged effect for many during pregnancy
Symptoms for pregnant women with COVID-19 can be prolonged, lasting two months or longer for a quarter of the women who participated in a national study led by UC San Francisco and UCLA.

Relaxed through pregnancy
A group of researchers from Charité - Universitätsmedizin Berlin have been able to show that maternal psychological wellbeing during pregnancy has a positive effect on newborn infants.

Trajectories of antidepressant medication use during pregnancy
In an analysis of women who started pregnancy when taking antidepressant medications, investigators identified three trajectories of antidepressant dispensing during pregnancy: more than half stopped their treatment, a quarter maintained their treatment throughout pregnancy, and one-fifth discontinued it for a minimum of three months and then resumed it during the postpartum period.

Are women using e-cigarettes during preconception and/or pregnancy?
A new study of 1,365 racially/ethnically diverse, low-income pregnant women found that 4% reported e-cigarette use.

A better pregnancy test for whales
To determine whale pregnancy, researchers have relied on visual cues or hormone tests of blubber collected via darts, but the results were often inconclusive.

Cannabis use during pregnancy
The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing.

Questions and answers about cannabis use during pregnancy
A new study shows that women have many medical questions about the use of cannabis both before and during pregnancy, and during the postpartum period while breastfeeding.

The effect of taking antidepressants during pregnancy
Exposure to antidepressants during pregnancy and the first weeks of life can alter sensory processing well into adulthood, according to research in mice recently published in eNeuro.

Is ivermectin safe during pregnancy?
Is it safe to give ivermectin to pregnant women? To answer this question, researchers from the Barcelona Institute for Global Health (ISGlobal), an institution supported by 'la Caixa,' conducted a systematic review and meta-analysis of studies that reported cases of accidental exposure to the drug among pregnant women.

Going to sleep on your back in late pregnancy
This study looked at whether going to sleep on your back in the third trimester of pregnancy was associated with average lower birth weights.

Read More: Pregnancy News and Pregnancy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.